1. Beaujouan, J. C., Torrens, Y., Viger, A., and Glowinski, J. (1984) A new type of tachykinin binding site in the rat brain characterized by the specific binding of a labeled eledoisin derivative. Mol. Pharmacol. 26,248–254.
2. Beaujouan, J.C., Torrens, Y., Saffroy, M., and Glowinski, J. (1986) Quantitative autoradiographic analysis of the distribution of binding sites for 125I-BoltonHunter derivatives of eledoisin and substance P in the rat brain. Neuroscience 18,857–875.
3. Beresford, I. J. M., Birch, P. J., Hagan, R. M., and Ireland, S. J. (1991) Investigation into species variants in tachykinin NK1 receptors by the use of the non-peptide antagonist, CP-96,345. Br. J. Pharmacol. 104,292–293.
4. Bergstrom, L., Beaujouan, J. C., Torrens, Y., Saffroy, M., Glowinski, J., Lavielle, S., Chassiang, G., Marquet, A., D’Orleans-Juste, P., Dion, S., and Regoli, D. (1987a) [3H]neurokinin A labels a specific tachykinin binding site in the rat duodenal smooth muscle. Mol. Pharmacol. 32,764–771.
5. Bergstrom, L., Torrens, Y., Saffroy, M., Beaujouan, J. C., Lavielle, S., Chassaing, G., Morgat, J. L., Glowinski, J., and Marquet, A. (1987b) 3H-neurokinin B and 125I-Bolton Hunter eledoisin label identical tachykinin binding sites in the rat brain. J. Neurochem. 48125–133.